Science for a better life

Speeches

Explanations to the Supervisory Board Report - Prof. Dr. Norbert Winkeljohann

Chairman of the Supervisory Board of Bayer AG

Address by Werner Baumann

Chairman of the Board of Management

February 25, 2021

Financial News Conference

Address by Werner Baumann and Wolfgang Nickl

Chairman of the Board of Management / Chief Financial Officer

November 3, 2020

News Conference Call for the Third Quarter of 2020

Address by Werner Baumann and Wolfgang Nickl

Chairman of the Board of Management / Chief Financial Officer

Investor Conference Call

SPEECHES

Bayer announces agreements to resolve major legacy Monsanto litigation

Annual Stockholders' Meeting

Address by Werner Baumann

Chairman of the Board of Management

February 27, 2020

Financial News Conference

Address by Werner Baumann

Chairman of the Board of Management

February 27, 2020

Financial News Conference

Address by Wolfgang Nickl

Member of the Board of Management

October 30, 2019

News Conference Call for the Third Quarter of 2019

Address by Werner Baumann

Chairman of the Board of Management

October 1, 2019

Future of Farming Dialogue 2019

Big Challenges Require Bolder Approaches

Liam Condon, Member of the Board of Management of Bayer AG and President of the Crop Science division of Bayer

October 1, 2019

Future of Farming Dialogue 2019

Today's Progress, Tomorrow's Possibilities

Dr. Bob Reiter, Global Head of Research and Development, Crop Science division of Bayer

October 2, 2019

Future of Farming Dialogue 2019

Sustainability at Bayer

Matthias Berninger, Head of Public Affairs and Sustainability, Bayer AG

October 2, 2019

Future of Farming Dialogue 2019

Shaping Agriculture to Benefit Farmers, Consumers and Our Planet

Klaus Kunz, Head of Sustainability and Business Stewardship, Crop Science division of Bayer

October 2, 2019

Future of Farming Dialogue 2019

Enhancing sustainability in our operations

Dr. Dirk Backhaus, Head of Product Supply, Crop Science division of Bayer

SPECIALIZED PRESS

Not intended for U.S. and UK Media - Important step towards improved treatment for children with venous thromboembolism

Rivaroxaban demonstrates strong efficacy and safety profile in phase III study in children with thromboembolism

Phase III EINSTEIN-Jr. study in children concludes the largest pediatric thromboembolism program delivering results consistent with those in adults

Annual Stockholders' Meeting

Address by Werner Baumann

Chairman of the Board of Management

February 27, 2019

Financial News Conference

Address by Wolfgang Nickl

Member of the Board of Management

February 27, 2019

Financial News Conference

Address by Werner Baumann

Chairman of the Board of Management

Download Center

0

file(s) collected

View Download Center

Press Kit Corona

Publications

Annual Report Quarterly Statement research – The Bayer Scientific Magazine

Publications Overview

Newsletter

We will keep you informed about the latest news.

Last updated: August 27, 2014